Dry weight management for patients with hemodialysis

doi:10.3877/cma.j.issn.2095-3216.2015.03.005

Abstract

Abstract:

Dry-weight is an important assessment index for adequacy of hemodialysis, and is vital for improving the survival rate as well as quality of life of patients. With the advances in medical practice, the dry weight definition has developed gradually and the concept evolved. Too high dry weight can affect blood pressure, cardiovascular system stability, and inflammatory factors, while too low dry weight may increase the risk of vascular access obstruction and loss of residual renal function, and increase hypotension-related complications during hemodialysis. Currently clinical methods for evaluation on dry weight includes clinical evaluation, determination for diameter of the inferior vena cava, isotope determination, determination of plasma markers, non-invasive blood volume monitor, and bio-electrical impedance spectra analysis, and so on, but each method has its limitations. Clinically dry weight dissatisfaction is mainly because of patients′ failing to follow the doctor′s advice, short time of hemodialysis, and excess sodium intake, etc. Clinical analysis of patients′ specific conditions should be performed to take targeted measures for achieving the goal of dry weight.

Key words: Hemodialysis, Dry weight, Management

Guangli Wu, Yunshuang Chen. Dry weight management for patients with hemodialysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(03): 132-136.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.03.005

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I03/132

References 29

[1]	Thomson GE, Waterhouse K, McDonald HP Jr, et al. Hemodialysis for chronic renal failure. Clinical observations [J]. Arch Intern Med, 1967, 120(2): 153-167.
[2]	Charra B, Laurent G, Chazot C, et al. Clinical assessment of dry weight [J]. Nephrol Dial Transplant, 1996, 11(Suppl 2): 16-19.
[3]	Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status [J]. Semin Dial, 2009, 22(5): 480-482.
[4]	Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients [J]. Nephrol Dial Transplant, 2009, 24(5): 1574-1579.
[5]	Rodriguez HJ, Domenici R, Diroll A, et al. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line [J]. Kidney Int, 2005, 68(2): 854-861.
[6]	Goldstein SL, Smith CM, Currier H. Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis [J]. J Am Soc Nephrol, 2003, 14(8): 2127-2131.
[7]	Kayikcioglu M, Tumuklu M, Ozkahya M, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis [J]. Nephrol Dial Transplant, 2009, 24(3): 956-962.
[8]	Patel HP, Goldstein SL, Mahan JD, et al. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients [J]. Clin J Am Soc Nephrol, 2007, 2(2): 252-257.
[9]	Lee MJ, Doh FM, Kim CH, et al. Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients [J]. Am J Nephrol, 2014, 39(5): 427-435.
[10]	Avila-Diaz M, Ventura MD, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis [J]. Perit Dial Int, 2006, 26(5): 574-580.
[11]	Ortega Marcos O, Rodriguez I, Gallar P, et al. Importance of dry-weight assessment in well-being, appetite, nutritional status, and anaemia correction in haemodialysis patients [J]. Nephrol Dial Transplant, 1998, 13(9): 2424.
[12]	Mundinger TO, Cummings DE, Taborsky GJ Jr. Direct stimulation of ghrelin secretion by sympathetic nerves [J]. Endocrinology, 2006, 147(6): 2893-2901.
[13]	Agarwal R1, Weir MR. Dry-weight a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients [J]. Clin J Am Soc Nephrol, 2010, 5(7): 1255-1260.
[14]	Basso F, Milan Manani S, Cruz DN, et al. Comparison and reproducibility of techniques for fluid status assessment in chronic hemodialysis patients [J]. Cardiorenal Med, 2013, 3(2): 104-112.
[15]	Oei EL, Fan SL. Practical aspects of volume control in chronic kidney disease using whole body bioimpedance [J]. Blood Purif, 2015, 39 (1-3): 32-36.
[16]	Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients [J]. Kidney Int, 2014, 86(3): 489-496.
[17]	Kron J, Schneditz D, Leimbach T, et al. A simple and feasible method to determine absolute blood volume in hemodialysis patients in clinical practice [J]. Blood Purif, 2014, 38(3-4): 180-187.
[18]	Sinha AD, Light RP, Agarwal R. Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight [J]. Hypertension, 2010, 55(2): 305-311.
[19]	Rodriguez HJ, Domenici R, Diroll A, et al. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line [J]. Kidney Int, 2005, 68(2): 854-861.
[20]	Chan C, Smith D, Spanel P, et al. A non-invasive, on-line deuterium dilution technique for the measurement of total body water in haemodialysis patients [J]. Nephrol Dial Transplant, 2008, 23(6): 2064-2070.
[21]	Fagugli RM, Pasini P, Quintaliani G, et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients[J]. Nephrol Dial Transplant, 2003, 18(11): 2332-2338.
[22]	Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long term survival on dialysis [J]. Am J Nephrol, 1996, 16(1): 35-44.
[23]	Movilli E1, Camerini C, Gaggia P, et al. Role of dialysis sodium gradient on intradialytic hypertension: an observational study [J]. Am J Nephrol, 2013, 38 (5): 413-419.
[24]	Hayashi SY, Seeberger A, Lind B, et al. Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: a tissue Doppler study [J]. Nephrol Dial Transplant, 2008, 23(4): 1355-1361.
[25]	Davies S, Carlsson O, Simonsen O, et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status [J]. Nephrol Dial Transplant, 2009, 24(5): 1609-1617.
[26]	Cook NR, Cutler JA, Obarzanek E, et al. Long-term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention [J]. BMJ, 2007, 334(7599): 885-888.
[27]	Ritz E, Dikow R, Morath C, et al. Salt- a potential 'uremic toxin’[J]? Blood Purif, 2006, 24(1): 63-66.
[28]	Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS [J]. Kidney In, 2006, 699(7): 1222-1228.
[29]	Shahgholian N, Hashemi MS, Shahidi S. Efficacy of stepwise sodium profile versus individualized dialysate sodium in blood pressure control among hemodialysis patients [J]. Iran J Nurs Midwifery Res, 2015, 20(1): 12-16.

Please choose a citation manager

Content to export